Zevra Therapeutics, Inc. Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-03-08 18:35:00 ET
More on Zevra Therapeutics, Inc.
- Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market
- Zevra Therapeutics appoints Justin Renz as CFO
- Seeking Alpha’s Quant Rating on Zevra Therapeutics, Inc.
Read the full article on Seeking Alpha
For further details see:
Zevra Therapeutics, Inc. Q4 2025 Earnings Preview
Zevra Therapeutics Inc.
NASDAQ: ZVRA
ZVRA Trading
7.08% G/L:
$9.10 Last:
387,525 Volume:
$8.81 Open:
ZVRA Latest News
ZVRA Stock Data
$484,721,776
54,946,394
0.39%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Celebration
